SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 73983.18
64.42 (0.09%)

Filter

Top Pharma Companies in India as on Jun-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Zydus Lifesciences Ltd.	Q V PT	1,11,264 Mid Cap	1,096.80 (-0.81%)	22.08	4.1	10.27	30.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	8,081 Small Cap	833.40 (-0.63%)	84.7	4.99	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Wockhardt Ltd.	Q V+ PT	30,663 Small Cap	1,832.85 (-2.87%)	143.96	6.21	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Windlas Biotech Ltd.	Q V PT	1,725 Small Cap	821.95 (-1.66%)	25.96	3.23	18.24	17.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Wanbury Ltd.	Q V+ PT	929 Small Cap	259.40 (-2.44%)	14.05	6.43	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Viyash Scientific Ltd.	Q V PT	11,241 Small Cap	254.30 (-1.17%)	63.41	3.86	5.64	-18.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Vimta Labs Ltd.	Q V+ PT	2,353 Small Cap	519.95 (-1.30%)	30.36	5.24	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Vijaya Diagnostic Centre Ltd.	Q V+ PT	13,368 Small Cap	1,276.80 (-1.72%)	77.28	13.97	15.00	18.43	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Unichem Laboratories Ltd.	Q V PT	2,662 Small Cap	439.40 (16.23%)	16.75	1.02	13.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,51,385 Large Cap	4,453.05 (-0.44%)	69.98	18.05	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Thyrocare Technologies Ltd.	Q V+ PT	8,721 Small Cap	532 (-2.91%)	53.37	15.07	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Themis Medicare Ltd.	Q V PT	971 Small Cap	103 (-2.32%)	N/A	3.62	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Tarsons Products Ltd.	Q V+ PT	1,141 Small Cap	207.35 (-3.31%)	50.36	1.69	12.30	-1.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Syngene International Ltd.	Q V+ PT	17,939 Small Cap	455 (2.39%)	58.84	3.81	10.89	4.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Syncom Formulations (India) Ltd.	Q V PT	1,371 Small Cap	14.02 (-3.84%)	18.03	3.32	17.63	21.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Suven Life Sciences Ltd.	Q V+ PT	6,983 Small Cap	268.45 (1.38%)	N/A	4.65	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Suraksha Diagnostic Ltd.	Q V PT	1,408 Small Cap	268.10 (-0.85%)	43.75	5.75	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Supriya Lifescience Ltd.	Q V+ PT	7,744 Small Cap	954.40 (-0.81%)	37.03	6.47	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,26,938 Large Cap	1,787.95 (0.48%)	37.19	5.11	9.87	23.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	6,792 Small Cap	205.80 (-1.67%)	4.38	5.09	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Strides Pharma Science Ltd.	Q V+ PT	9,381 Small Cap	977.95 (-3.92%)	51.09	2.86	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Solara Active Pharma Sciences Ltd.	Q V PT	2,784 Small Cap	575 (-0.51%)	N/A	2.22	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	SMS Pharmaceuticals Ltd.	Q V+ PT	3,535 Small Cap	381.40 (1.05%)	40.35	4.39	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Sigachi Industries Ltd.	Q V+ PT	801 Small Cap	21.12 (0.72%)	N/A	1.68	24.05	7.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Shree Ganesh Remedies Ltd.	Q V PT	792 Small Cap	570.15 (-7.59%)	44.56	4.86	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Shilpa Medicare Ltd.	Q V+ PT	11,089 Small Cap	560.20 (-1.19%)	45.57	4.28	7.22	-12.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Shalby Ltd.	Q V PT	1,828 Small Cap	165 (-2.48%)	16.19	1.47	12.52	25.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Senores Pharmaceuticals Ltd.	Q V+ PT	5,037 Small Cap	1,135 (3.77%)	248.75	6.72	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Sanofi India Ltd.	Q V PT	7,263 Small Cap	3,176.45 (0.72%)	23.45	9.31	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	10,841 Small Cap	4,653.70 (-1.13%)	42.03	23.99	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Unichem Lab	439.40	16.23%
Akums Drugs & Pharma	592.35	7.97%
Kwality Pharma	2,500	7.01%
3B Blackbio Dx	1,255	4%
Concord Biotech	1,322.25	3.99%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Panacea Biotec	547.65	-9.99%
Shree Ganesh Remed.	570.15	-7.59%
Gufic Biosciences	365.50	-5.79%
Park Medi World	280.40	-4.09%
Guj. Themis Biosyn	385.45	-4.05%

News about Top Pharma Companies in India

Jun, 2026

TGA completes inspection at Wanbury’s API manufacturing in Andhra Pradesh

GMP certificate once received, will enable Wanbury to ship additional 3 APIs

Jun, 2026

Wanbury expands regulatory submission for launch of new APIs

For Diphenhydramine HCl, the company has submitted DMF to Malaysia and Singapore

Jun, 2026

Vijaya Diagnostic Centre informs about investors meet

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Vijaya Diagnostic Centre has informed that the officials of the Company will be interacting with Institutional Investors/ Analysts in Emkay Global Financial Services (Non-Deal Roadshow) on Monday, June 15, 2026 & Tuesday, June 16, 2026 from 09:00 am to 06:00 pm (IST) in Singapore (One on One Meeting – In Person). The above information is also available on the website of the Company: https://www.vijayadiagnostic.com/investors/disclosure-of-events.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Viyash Scientific informs about acquisition

Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, Viyash Scientific has informed that, Alivira Animal Health Limited, Ireland, step-down wholly owned subsidiary of the Company, has entered into a binding agreement today i.e. June 8, 2026, for the acquisition of 100% shareholding of BioForLife Italia s.r.l., Milan, Italy. The aggregate consideration for the transaction is EUR 16.975 million, structured as follows: a. EUR 15.0 million payable at closing; and b. EUR 1.975 million as deferred consideration, in accordance with the terms of the transaction documents. The transaction is subject to fulfilment of the applicable conditions precedent and receipt of such statutory and regulatory approvals as are applicable to the transaction. The details required under Regulation 30 of the SEBI Listing Regulations read with the applicable SEBI circulars are enclosed as Annexure I.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Viyash Scientific signs binding agreement to acquire 100% stake in BFL

The transaction represents a significant step in its strategy to capitalize on the mega-trend of a growing companion Animal Health Generics market

Jun, 2026

SMS Pharmaceuticals informs about disclosure

SMS Pharmaceuticals has informed that the Company had received a request from a shareholder holding shares in physical form for updating KYC documents through the Registrar and Share Transfer Agent (RTA) of the Company. Upon verification of the KYC documents submitted by the shareholder, the Company observed that the said shares had already been claimed by another person impersonating the original shareholder. Accordingly, the Company initiated a detailed enquiry and carried out verification of the documents and transfer records relating to the said shares.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Zydus Lifesciences Ltd.	1,11,264 Crore
2	Yatharth Hospital & Trauma Care Services Ltd.	8,081 Crore
3	Wockhardt Ltd.	30,663 Crore
4	Windlas Biotech Ltd.	1,725 Crore
5	Wanbury Ltd.	929 Crore
6	Viyash Scientific Ltd.	11,241 Crore
7	Vimta Labs Ltd.	2,353 Crore
8	Vijaya Diagnostic Centre Ltd.	13,368 Crore
9	Unichem Laboratories Ltd.	2,662 Crore
10	Torrent Pharmaceuticals Ltd.	1,51,385 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,544	55,558	35.80	11.64	24.45	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,453	1,51,385	69.98	18.05	36.96	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,075	37,632	35.64	8.31	24.09	24.45
Lupin Ltd. (M)	Somewhat Good	2,246	1,03,490	19.41	4.61	11.23	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,097	1,11,264	22.08	4.10	13.54	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,385	76,956	114
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,453	1,51,385	40.69
Gland Pharma Ltd. (S)	Very Good	2,266	37,741	38.82
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,144	62,289	38.09
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,200	35,481	31.79
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,200	35,481	52.63	8.79	31.88	15.51
Mankind Pharma Ltd. (M)	Very Good	2,369	98,745	48.46	6.02	30.50	14.65
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,274	1,05,899	25.24	2.79	13.93	13.26
Ajanta Pharma Ltd. (M)	Very Good	3,075	37,632	35.64	8.31	24.09	12.43
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,453	1,51,385	69.98	18.05	36.96	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,097	1,11,264	22.08	4.10	13.54	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,788	4,26,938	37.19	5.11	21.29	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,274	1,05,899	25.24	2.79	13.93	22.29
Abbott India Ltd. (M)	Very Good	26,544	55,558	35.80	11.64	24.45	18.78
Ajanta Pharma Ltd. (M)	Very Good	3,075	37,632	35.64	8.31	24.09	17.07

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

TGA completes inspection at Wanbury’s API manufacturing in Andhra Pradesh

Wanbury expands regulatory submission for launch of new APIs

Vijaya Diagnostic Centre informs about investors meet

Viyash Scientific informs about acquisition

Viyash Scientific signs binding agreement to acquire 100% stake in BFL

SMS Pharmaceuticals informs about disclosure

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.